Infinity Bio, Inc.
Jean-Philippe Laine has a diverse background in business development and sales, with experience in various companies specializing in microbiome profiling, metabolomics, DNA and RNA testing, and DNA sequencing. Jean-Philippe holds a Ph.D. in Molecular Biology from Université Louis Pasteur and has worked in post-doc positions at UMDNJ and IGBMC. Currently, Jean-Philippe holds the position of Vice President of Business Development & Sales at Infinity Bio, Inc. and has previously held roles such as Director of Business Development and Service Coordination at Diversigen, Inc., Business Development US at Microba Life Sciences, and VP of Business Development at Diversigen, Inc. (formerly known as Metanome).
This person is not in any teams
Infinity Bio, Inc.
Infinity Bio is a Circulating Antibody Repertoire Profiling service company, leveraging a novel technology, MIPSA (Molecular Indexing of Proteins (or Peptides) by Self Assembly) developed by Dr. H. Ben Larman, a pioneer in this field. Our various antigen libraries provide cost effective, comprehensive and quantitative analyses of antibody responses to infections, vaccinations, self-antigens and allergens. Our proprietary method allows for the rapid and flexible content customization. Infinity Bio can design and create customer specific peptide libraries against any target of choice.